Nurix Therapeutics, Inc. (NRIX) dividend history
NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3073% below fair value
$15.48−0.12 (-0.77%)
Close on Nov 13, 2026Market cap $1.69BP/E 6.7Yield 0.00%
Dividends
Nurix Therapeutics has not reported a dividend
No dividend per share appears in Nurix Therapeutics's annual filings since fiscal 2018.
See a number that looks wrong?